BlossomHill Therapeutics

BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune diseases. The company is building a deep pipeline of drug candidates across a range of targets with the aim of achieving the next leap forward in patient care. Their approach to drug design and development begins by considering medical needs through an in-depth understanding of the science behind the disease, then seeks to design a novel chemotype to maximize the chances of success.